Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.

Biotechnology

Health Care

Entact Bio

Victoria Richon

Stefanie Schalm

Victor Serebrov

Simon Bushell

Paul Perkins

Owen Smith

Elma Kadic

Bob Soh

Biological Sciences Research

Leadership Team

Research and Development

Teams at Entact Bio

Biological Sciences Research

Leadership Team

Research and Development